Case report Po Wen Cheng,1 Ruei An Tsai,1 Chien-­Hui Lee,2 Wen-­Ching Chen1 1 General Psychiatry Department, Yuli Hospital, Ministry of Health and Welfare, Hualien, Taiwan 2 Department of Neurosurgery, Buddhist Tzu-­Chi General Hospital and Tzu-­Chi University, Hualien, Taiwan Correspondence to Dr Wen-­Ching Chen; ​f90841021@​ntu.e​ du.​tw Accepted 7 November 2023 © BMJ Publishing Group Limited 2023. Re-­use permitted under CC BY-­NC. No commercial re-­use. See rights and permissions. Published by BMJ. To cite: Cheng PW, Tsai RA, Lee C-­H, et al. BMJ Case Rep 2023;16:e255286. doi:10.1136/bcr-2023255286 SUMMARY A male patient in his 70s with chronic schizophrenia, who could previously walk independently, developed a gait disturbance without any significant neurological deficit. Initially, his short step length and unstable gait were thought to be related to extrapyramidal symptoms caused by medication side effects. We tapered his antipsychotic medication, but the unstable gait persisted. After 2 weeks of observation, we noted general weakness with left-­side dominance, leading us to consider a focal brain lesion despite there being no recent history of falling or trauma. A CT scan of the brain showed chronic subdural haematoma and the patient underwent emergency surgery. After 14 days of treatment, he was discharged back to the chronic ward. CASE PRESENTATION A male patient in his 70s with chronic schizophrenia, the onset of which occurred in his early 20s, had been in long-­term hospital care in Taiwan for over 40 years. He had been taking olanzapine 5 mg and valproic acid 400 mg daily for about 3 years and was transferred to the acute ward due to violent behaviour towards another patient, which suggested exacerbation of symptoms. After his admission to the acute ward, we continued to administer his current psychiatric medication. He had a relatively stable mood, could cooperate with ward activity and could walk independently with no violent behaviour noted. However, he had a short step length with unstable gait—the typical manifestation of an extrapyramidal gait disturbance—and leaned forward while walking. He started using a wheelchair due to his gait disturbance about 1 week after his transfer to the ward. No seizures, dizziness, BACKGROUND headache or recent falling episode was noted on Extrapyramidal symptoms (EPS) are one of the the ward. Three weeks after being transferred, his most common adverse effects observed in patients laboratory results showed normal levels of serum taking antipsychotics. Also referred to as drug-­ sodium, potassium, chloride, calcium, creatinine, induced movement disorders, the symptoms of blood urea nitrogen, aspartate aminotransferase EPS include dystonia, akathisia and Parkinsonism. and alanine aminotransferase, as well as normal In addition, prolonged use of antipsychotics can red and white cell counts. We considered psychicause tardive dyskinesia. Drug-­induced EPS results atric medication side effects related to EPS and thus from antagonism of dopamine D2 receptors, one tapered and then withheld his psychiatric medicaof the main actions of antipsychotics, especially tion. However, the patient still had general weakin first-­generation drugs such as haloperidol and ness after we withheld his psychiatric medication for fluphenazine. Although blocking of D2 receptors 7 days. He became bedridden due to general weakin the mesolimbic pathway can improve psychotic ness. We observed no improvement in EPS after symptoms, blockage of the same receptors in the olanzapine was completely discontinued, and so we nigrostriatal pathway may result in the unwanted consulted a neurologist for evaluation. Neurologeffects of EPS.1 When the blockage becomes long ical examination showed decreased muscle power term, overexpression of downstream D2 receptors may occur to compensate for the lack of dopamine, which manifests clinically as tardive dyskinesia.2 Treatment usually includes discontinuing the current antipsychotics, or prescribing anticholinergics such as biperiden or trihexyphenidyl. EPS can be very damaging to the patient‘s quality of life and is one of the major reasons for patients dropping out of pharmacotherapy, which can directly increase the risk of relapse and rehospitalisation. Dealing with EPS is a significant part of clinical practice and a familiar scenario in the psychiatry field. Medication is not the only cause of EPS, however. Organic Figure 1 (A) Brain CT scan before surgical intervention. brain injuries,3 for instance, may mimic such symp- The initial CT before surgery revealed chronic subdural toms. Because of the potentially lethal nature of haematoma at right frontal, temporal and parietal region brain injuries, timely and correct identification of with midline shift about 9 mm. (B) Brain CT scan after the cause of symptoms is crucial. Reported here is surgical intervention. The postoperative brain CT revealed a case of chronic subdural haematoma (SDH) that minimal subdural effusion without midline shift was manifested as EPS, which was initially approached noted. The trephination surgery relieved mass effect due as drug-­induced EPS. to chronic subdural haematoma. Cheng PW, et al. BMJ Case Rep 2023;16:e255286. doi:10.1136/bcr-2023-255286 1 BMJ Case Rep: first published as 10.1136/bcr-2023-255286 on 1 December 2023. Downloaded from http://casereports.bmj.com/ on April 18, 2024 by guest. Protected by copyright. Chronic subdural haematoma mimicking extrapyramidal symptoms Case report INVESTIGATIONS In order to rule out intracranial haemorrhage, infarction or brain tumour, we arranged for the patient to undergo a CT scan of the brain. TREATMENT Surgical indications for SDH include neurological deficit and massive mass effect with a midline shift of more than 5 mm. We arranged emergency trephination of the chronic SDH in the right parietal region, with a finding of>150 mL dark-­ brown blood (motor oil like). The right parietal Jackson-­Pratt drainage tube was removed at postoperative day 2. OUTCOME AND FOLLOW-UP The patient was transferred back to the hospital after being discharged from the medical centre and underwent regular follow-­up. He regained clear consciousness and can walk and eat independently. These symptoms may be misleading in patients with underlying psychiatric disorders who are taking antipsychotic medication. Because such movement disturbances are a common concern in patients who use antipsychotics, as psychiatrists, we initially considered the disturbance in the present case to be olanzapine-­ related EPS. We did not consider the possibility of a focal neurological lesion until we consulted the neurologist. The neurological examination showed decreased muscle power of the left limbs, a positive left Babinski sign and hyperactive knee jerk, triceps reflex, and brachioradialis reflex on the left side, which implied reflex asymmetry, alerting us to the possibility of a brain lesion. This case highlights that medications such as antipsychotics are not the only cause of EPS. An organic brain injury, such as chronic SDH, may mimic these symptoms. Because chronic SDH can be lethal, its timely detection and treatment is crucial. Learning points ► In patients receiving antipsychotic treatment, medication side effects are often overemphasised when symptoms related to gait, weakness or alertness are observed. ► Such symptoms may instead be caused by a new medical condition such as an organic brain injury. ► With a progressing brain injury, timely and correct identification of the cause of the symptoms is crucial. ► The presence of a focal brain lesion may initially present as a feature mimicking extrapyramidal symptoms. Contributors This case was cared by Po Wen Cheng and Rue An Tsai under the supervision of Wen-­Ching Chen. Surgical intervention was done by Chieu-­Hui Lee. The report was written and discussed by all co-­authors. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-­for-­profit sectors. Competing interests None declared. DISCUSSION The presentation of chronic SDH can vary from no symptoms to decreased memory, confusion, weakness or numbness of the arms, legs and face and difficulty in speech and walking. Movement disorders such as Parkinsonism can also be associated with SDH. Elderly people with subacute progressive Parkinsonism should therefore undergo CT studies to differentiate it from primary Parkinsonism. The aetiology of chronic SDH includes head injury, subdural effusion, cerebrospinal fluid leakage and spontaneous intracranial hypotension, especially in young-­aged patients to middle-­ aged patients, even without preceding trauma or haematological disorders. Surgery is the best treatment option for chronic SDH involving moderate-­to-­large haematoma with accompanying neurological deficits. The ideal treatment strategy should be tailored to the individual patient’s condition. Careful supportive treatment can be considered if it is well tolerated.4 In the present case, SDH was not diagnosed at our initial impression due to the lack of neurological deficits and trauma history. A patient with SDH may also initially present with withdrawn behaviour, the absence of speech, apathy, blunted affect and poor self-­care, which may be thought to be manifestations of psychosis.5 Moreover, in many cases of chronic SDH, reversible Parkinson-­like symptoms are the acute presenting feature.6 2 Patient consent for publication Consent obtained directly from patient(s). Provenance and peer review Not commissioned; externally peer reviewed. Open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-­NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-­commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-­commercial. See: http://creativecommons.org/​ licenses/by-nc/4.0/. Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy. REFERENCES 1 Nevena D, Milica P, Igor J, et al. Second-­generation antipsychotics and extrapyramidal adverse effects. BioMed Res Int 2014: 2 Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-­onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982;32:1335–46. 3 Scott O, Hasal S, Goez HR. Basal ganglia injury with extrapyramidal presentation: a complication of meningococcal meningitis. J Child Neurol 2013;28:1489–92. 4 Yadav YR, Parihar V, Namdev H, et al. Chronic subdural hematoma. Asian J Neurosurg 2016;11:330–42. 5 Kar SK, Kumar D, Singh P, et al. Psychiatric manifestation of chronic subdural hematoma: the unfolding of mystery in a homeless patient. Indian J Psychol Med 2015;37:239–42. 6 Guppy KH, Khandhar SM, Ochi C. Reversible Parkinson-­like symptoms in patient with bilateral chronic subdural hematomas and cervical spinal stenosis. World Neurosurg 2018;109:285–90. Cheng PW, et al. BMJ Case Rep 2023;16:e255286. doi:10.1136/bcr-2023-255286 BMJ Case Rep: first published as 10.1136/bcr-2023-255286 on 1 December 2023. Downloaded from http://casereports.bmj.com/ on April 18, 2024 by guest. Protected by copyright. of the left limbs, a positive left Babinski sign and hyperactive knee jerk, triceps reflex and brachioradialis reflex on the left side. Thus, a focal brain lesion in the right hemisphere was suspected. The patient was transferred to a general hospital for further evaluation. A CT scan of his brain showed chronic SDH in the right frontal, temporal and parietal lobes (figure 1A). He was then transferred to a medical centre for surgical intervention by means of trephination of the chronic SDH in the right parietal region. A follow-­up CT scan of the brain revealed only minimal subdural effusion without a midline shift (figure 1B). The drainage tube was removed, following which the patient’s limb weakness improved. After his surgical stitches were removed, the patient was discharged and transferred back to the hospital in stable condition. He is currently in the chronic ward with clear consciousness and improved muscle power. Case report BMJ Case Rep: first published as 10.1136/bcr-2023-255286 on 1 December 2023. Downloaded from http://casereports.bmj.com/ on April 18, 2024 by guest. Protected by copyright. Copyright 2023 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit https://www.bmj.com/company/products-services/rights-and-licensing/permissions/ BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission. Become a Fellow of BMJ Case Reports today and you can: ► Submit as many cases as you like ► Enjoy fast sympathetic peer review and rapid publication of accepted articles ► Access all the published articles ► Re-use any of the published material for personal use and teaching without further permission Customer Service If you have any further queries about your subscription, please contact our customer services team on +44 (0) 207111 1105 or via email at support@bmj.com. Visit casereports.bmj.com for more articles like this and to become a Fellow Cheng PW, et al. BMJ Case Rep 2023;16:e255286. doi:10.1136/bcr-2023-255286 3